Cargando…
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents
Smallpox is an acute disease caused by infection with variola virus that has had historic effects on the human population due to its virulence and infectivity. Because variola remains a threat to humans, the discovery and development of novel pox therapeutics and vaccines has been an area of intense...
Autores principales: | Roy, Chad J., Voss, Thomas G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954426/ https://www.ncbi.nlm.nih.gov/pubmed/20953322 http://dx.doi.org/10.3390/v2092096 |
Ejemplares similares
-
Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE(®) against aerosolized rabbitpox virus in a rabbit model()
por: Garza, Nicole L., et al.
Publicado: (2009) -
Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule
por: Perry, Mark R., et al.
Publicado: (2018) -
Monkeypox Virus Infections in Small Animal Models for Evaluation of Anti-Poxvirus Agents
por: Hutson, Christina L., et al.
Publicado: (2010) -
Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
por: Rice, Amanda D., et al.
Publicado: (2011) -
In vitro activity of potential anti-poxvirus agents
por: Kern, Earl R
Publicado: (2003)